Novavax slashes sales guidance in half, stock plunges 30%
admin Novavax Inc. executives slashed their annual sales guidance in half Monday while wildly missing financial…
Read MoreNovavax
Official U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children
The daily average of new U.S. cases may have started to decline based on official…
Read MoreOfficial U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children
The daily average of new U.S. cases may have started to decline based on official…
Read MoreNew omicron variant worries experts as it spreads in India, and Moderna says new booster offers better protection against BA.4 and BA.5
A new, highly infectious subvariant of omicron is raising concerns among scientists and health experts…
Read MoreNovavax is part of the FDA’s COVID-19 booster debate, but its vaccine still hasn’t been authorized
Novavax’s NVAX, +1.04% COVID-19 vaccine candidate played a front-and-center role during this week’s debate about…
Read More